NCT04005690 2026-02-27Targeted Pathway Inhibition in Patients With Pancreatic CancerOHSU Knight Cancer InstitutePhase EARLY_PHASE1 Recruiting90 enrolled
NCT03943173 2026-02-25Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before SurgeryM.D. Anderson Cancer CenterPhase EARLY_PHASE1 Active not recruiting15 enrolled